Industry News
Pharmaceutical Industry News
Oklahoma to Continue Lethal Injections After Man Vomits During Execution
It was the state’s first lethal injection since 2015, when it halted executions after using the wrong drug in one instance and allowing a prisoner to regain consciousness in another.
Why Aren’t More People Comparison Shopping for Health Plans?
Most Medicare beneficiaries don’t compare plans during open enrollment season, and may be paying more, or accepting more restrictions, than they should.
Novo Nordisk casts Queen Latifah in TV-themed awareness campaign for obesity
Novo Nordisk casts Queen Latifah in TV-themed awareness campaign for obesity nmissakian Fri, 10/29/2021 - 17:31
Pfizer’s COVID vaccine for younger kids meets FDA bar, with CDC panel next week being key to wide rollout
Pfizer’s COVID vaccine for younger kids meets FDA bar, with CDC panel next week being key to wide rollout kdunleavy Fri, 10/29/2021 - 16:04
Seagen stands by newly acquired HER2 breast cancer drug despite competition from AstraZeneca-Daiichi’s Enhertu
Seagen stands by newly acquired HER2 breast cancer drug despite competition from AstraZeneca-Daiichi's Enhertu kdunleavy Fri, 10/29/2021 - 15:38
¿Qué vacuna de refuerzo debo elegir?
Las autoridades sanitarias de EE. UU. autorizaron la combinación de vacunas en la dosis de refuerzo contra la covid, pero no han indicado cuál es la mejor opción.
Even AbbVie CEO can’t confirm Rinvoq’s sales as FDA mulls JAK label
Even AbbVie CEO can't confirm Rinvoq's sales as FDA mulls JAK label aliu Fri, 10/29/2021 - 11:49
AbbVie’s Vraylar turns in mixed results in depression, but pharma decides to file for approval anyway
AbbVie’s Vraylar turns in mixed results in depression, but pharma decides to file for approval anyway aliu Fri, 10/29/2021 - 10:23
Pacira panel takes on uncomfortable women’s health topics to help women
Pacira panel takes on uncomfortable women's health topics to help women sharon.coey Fri, 10/29/2021 - 08:57
Resurgeant Veklury delivers Gilead $1.9 billion in sales and an earnings surprise
Resurgeant Veklury delivers Gilead $1.9 billion in sales and an earnings surprise kdunleavy Fri, 10/29/2021 - 07:24
Resurgent Veklury delivers Gilead $1.9B in sales and an earnings surprise
Resurgent Veklury delivers Gilead $1.9B in sales and an earnings surprise kdunleavy Fri, 10/29/2021 - 07:24
Fierce Pharma Asia—Takeda’s GammaDelta buy, FDA warning letter removal; Fujifilm’s massive North Carolina plant
Fierce Pharma Asia—Takeda's GammaDelta buy, FDA warning letter removal; Fujifilm's massive North Carolina plant aliu Fri, 10/29/2021 - 06:16
Merck’s big earnings in Q3 play second fiddle to enthusiasm for COVID pill’s potential
Merck's big earnings in Q3 play second fiddle to enthusiasm for COVID pill's potential kdunleavy Thu, 10/28/2021 - 11:15
Alnylam founding CEO Maraganore steps down after pioneering RNA interference therapy
Alnylam founding CEO Maraganore steps down after pioneering RNA interference therapy aliu Thu, 10/28/2021 - 10:42
Up to 50M J&J COVID doses sit idle at Emergent plant, awaiting FDA inspection: report
Up to 50M J&J COVID doses sit idle at Emergent plant, awaiting FDA inspection: report jkeenan Thu, 10/28/2021 - 09:29
Takeda’s Japan plant reemerges from FDA warning letter as pharma works through pipeline setbacks
Takeda's Japan plant reemerges from FDA warning letter as pharma works through pipeline setbacks aliu Thu, 10/28/2021 - 09:02
Sanofi’s €10B sales target for Dupixent? The ‘megabrand’ is more than halfway there, exec says
Sanofi's €10B sales target for Dupixent? The 'megabrand' is more than halfway there, exec says esagonowsky Thu, 10/28/2021 - 08:43
Strides Pharma to pump $42M into former Endo manufacturing plant in New York
Strides Pharma to pump $42M into former Endo manufacturing plant in New York jkeenan Thu, 10/28/2021 - 08:20
How to Decide Which Covid Booster Shot to Get
Health officials approved mix-and-match Covid booster shots, but didn’t say whether it’s better to switch vaccines or stick with your original shot.
Fluvoxamine Helps Lower Risk of Hospitalization From Covid, Study Finds
Scientists say the results of the latest research examining the inflammation-fighting qualities of fluvoxamine, capping similar smaller studies, could lead to new treatment guidelines.